PRESTIGE CONSUMER HEALTHCARE INC. Property, Plant and Equipment
PRESTIGE CONSUMER HEALTHCARE INC. (PBH) had Property, Plant and Equipment of $117.18 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-08-06
- 2026-06-30: Property, Plant and Equipment, Net $117.18M.
- 2026-03-31: Property, Plant and Equipment, Net $121.69M.
- 2025-12-31: Property, Plant and Equipment, Net $128.21M.
- 2025-09-30: Property, Plant and Equipment, Net $73.10M.
| Period end | Property, Plant and Equipment, Net | Property, Plant and Equipment, Net as first filed |
|---|---|---|
| 2026-06-30 | $117.18M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $121.69M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $128.21M 10-Q · filed 2026-02-05 | |
| 2025-09-30 | $73.10M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $73.79M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $74.55M 10-K · filed 2026-05-14 | |
| 2024-12-31 | $73.52M 10-Q · filed 2025-02-06 | |
| 2024-09-30 | $74.92M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $75.41M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $76.51M 10-K · filed 2025-05-09 | |
| 2023-12-31 | $70.36M 10-Q · filed 2024-02-08 | |
| 2023-09-30 | $70.70M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $69.98M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $70.41M 10-K · filed 2024-05-15 | |
| 2022-12-31 | $69.57M 10-Q · filed 2023-02-02 | |
| 2022-09-30 | $69.95M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $70.39M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $71.30M 10-K · filed 2023-05-05 | |
| 2021-12-31 | $69.81M 10-Q · filed 2022-02-03 | |
| 2021-09-30 | $70.02M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $69.83M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $70.06M 10-K · filed 2022-05-06 | |
| 2020-12-31 | $68.62M 10-Q · filed 2021-02-04 | |
| 2020-09-30 | $65.16M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $58.33M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $55.99M 10-K · filed 2021-05-07 | |
| 2019-12-31 | $53.23M 10-Q · filed 2020-02-06 | |
| 2019-09-30 | $52.50M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $51.39M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $51.18M 10-K · filed 2020-05-08 | |
| 2018-12-31 | $51.57M 10-Q · filed 2019-02-07 | |
| 2018-09-30 | $52.32M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $52.45M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $52.55M 10-K · filed 2019-05-13 | |
| 2017-12-31 | $51.06M 10-Q · filed 2018-02-01 | |
| 2017-09-30 | $49.57M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $50.47M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $50.59M 10-K · filed 2018-05-10 | |
| 2016-12-31 | $12.87M 10-Q · filed 2017-02-02 | |
| 2016-09-30 | $13.73M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $15.08M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $15.54M 10-K · filed 2017-05-17 | |
| 2015-12-31 | $12.30M 10-Q · filed 2016-02-04 | |
| 2015-09-30 | $12.92M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $13.15M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $13.74M 10-K · filed 2016-05-17 | |
| 2014-12-31 | $13.09M 10-Q · filed 2015-02-05 | |
| 2014-09-30 | $12.42M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $10.67M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $9.60M 10-K · filed 2015-05-14 | |
| 2013-12-31 | $10.53M 10-Q · filed 2014-02-07 | |
| 2013-09-30 | $11.26M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $10.70M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $9.90M 10-K · filed 2014-05-19 | |
| 2012-12-31 | $9.19M 10-Q · filed 2013-02-07 | |
| 2012-09-30 | $6.13M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $2.28M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $9.90M 10-Q · filed 2013-08-01 | $1.30M 10-K · filed 2012-05-18 |
| 2011-12-31 | $1.24M 10-Q · filed 2012-02-09 | |
| 2011-09-30 | $1.38M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $1.34M 10-Q · filed 2011-08-05 | |
| 2011-03-31 | $1.44M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |